Articles tagged with "Drug Discovery"

Sort by

Open-Source AI-derived drug discovery data to help combat COVID-19

April 27, 2020
Recursion, a digital biology company industrialising drug discovery, released its open-source RxRx19 dataset; the first human cellular morphological dataset of SARS-CoV-2 (COVID-19). The human cellular morphological data and over 1,600...

New collaboration to drive understanding of COVID-19

April 26, 2020
A new collaboration between Medicines Discovery Catapult, Retrogenix and Peak Proteins will work to identify target receptors for COVID-19 and advance understanding of the cellular mechanisms of infection by COVID-19.

CERN takes on Covid-19

April 9, 2020
The World’s biggest experiment, CERN, has established a task force to identify and support contributions from the Organization’s global community to combatting the COVID-19 pandemic.

Antibody from SARS epidemic reacts with Coronavirus

April 9, 2020
An antibody recovered from a survivor of the SARS epidemic in the early 2000s has revealed a potential vulnerability of COVID-19, according to a new study.

AMR Centre nominates MBL inhibitor

November 11, 2019
The AMR Centre has nominated a preclinical candidate molecule for its programme to overcome resistance mechanisms in bacteria.

Procarta awarded £7.4M for microbial treatment

September 23, 2019
Biotechnology company Procarta Biosystems will receive up to £7.4 million to develop a new class of antibiotics in the fight against antimicrobial resistance.

Seven virtual data hubs to boost health R&D

September 13, 2019
The UK government is funding seven new virtual data-sharing hubs to help develop new treatments for diseases including cancer, Crohn’s disease and asthma.

Pin It on Pinterest